Citation 148848

LE BAIL,JC: CHAMPAVIER,Y: CHULIA,AJ: HABRIOUX,G:. (2000). EFFECTS OF PHYTOESTROGENS ON AROMATAS, 3-BETA AND 17-BETA-HYDROXYSTEROID DEHYDROGENASE ACTIVITIES AND HUMAN BREAST CANCER CELLS.. 66(14)

Citation Details

Title	EFFECTS OF PHYTOESTROGENS ON AROMATAS, 3-BETA AND 17-BETA-HYDROXYSTEROID DEHYDROGENASE ACTIVITIES AND HUMAN BREAST CANCER CELLS.
Authors	LE BAIL,JC: CHAMPAVIER,Y: CHULIA,AJ: HABRIOUX,G:
Year	2000
Volume	66
Issue	14

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	ACTIVE
2	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
3	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
4	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY:	ACTIVE
5	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY:	INACTIVE
6	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-HYDROXY:	ACTIVE
7	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-METHOXY:	ACTIVE
8	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-METHOXY:	INACTIVE
9	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-METHOXY:	INACTIVE
10	ATP-ASE(CA++) STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-8-DIHYDROXY:	ACTIVE
11	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-8-DIHYDROXY:	INACTIVE
12	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-8-DIHYDROXY:	INACTIVE
13	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
14	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
15	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
16	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
17	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
18	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
19	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
20	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
21	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
22	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTROL	ACTIVE
23	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTROL	WEAK ACTIVITY
24	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTROL	ACTIVE
25	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	INACTIVE
26	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
27	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
28	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	INACTIVE
29	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE
30	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE
31	ATP-ASE(CA++) STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
32	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
33	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
34	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
35	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
36	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
37	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PRUNETIN	INACTIVE
38	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PRUNETIN	INACTIVE
39	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PRUNETIN	INACTIVE
40	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 3-4-7-TRIHYDROXY:	INACTIVE
41	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 3-4-7-TRIHYDROXY:	INACTIVE
42	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 3-4-7-TRIHYDROXY:	ACTIVE

Galega officinalis (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	MEDICARPIN	None
2	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	INACTIVE
3	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	INACTIVE
4	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	INACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	SATIVAN	None
6	AROMATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SATIVAN	INACTIVE
7	HYDROXYSTEROID(3-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SATIVAN	INACTIVE
8	HYDROXYSTEROID(17-BETA) DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SATIVAN	INACTIVE